Pediatric Exclusivity: How FDA Extends Patent Protection for Drugs

Pediatric Exclusivity: How FDA Extends Patent Protection for Drugs

Pediatric exclusivity gives drug companies six extra months of market protection by blocking generic approval-not by extending patents, but by delaying FDA decisions. It’s a powerful tool that benefits children’s health and pharmaceutical profits alike.

View More